The reproduced May1945 memo explicitly lists Kammler among personnel held for interrogation. It also describes ordinary technical intelligence collection, with acquired, planned, incomplete and untested items kept distinct. The held-list wording is stronger than a future interview request, but this reproduction does not independently authenticate custody or establish a UAP programme.
■ Complete selected reproduced memo; original archive and fine-detail gaps
Kevin Knuth (speaker), Douglas Dean Johnson (transcriber). douglasjohnson.ghost.io.
Knuth describes claimed Stanford imagery while explicitly stating that it has not been independently vetted or authenticated. Reported filming, relayed viewing and comparisons to technical concepts remain distinct; the excerpt does not validate the object or its propulsion.
■ Selected written narration reviewed; full talk and imagery pending
U.S. National Archives and Records Administration. archives.gov.
The National Archives describes JIOA’s establishment, Overcast and Paperclip duties, and dissolution in1962. Its foreign-scientist finding aid supplies names and box locations rather than dossier contents. The page explicitly notes that von Braun’s dossier was never transferred. Archival mention, missing entries and ordinary recruitment history do not establish criminal guilt, a UFO programme or a specific family’s later account.
■ Complete supplied description and finding-aid text; dossier contents unreviewed
Garry Nolan, Congressionally Directed Medical Research Programs. cdmrp.health.mil.
The public Defense programme booklet identifies Nolan as the OCRP2011 Teal Innovator. His perspective reports ovarian-cancer cohort classification and describes hoped-for clinical benefits. This documents a public biomedical programme association; it establishes no classified UAP approach or access.
■ Selected Nolan perspective and programme context read
An FDA contract listing names Stanford University for 75F40120C00176, independently of the MaxFuse acknowledgement. The requirement concerns coronavirus research. Its wording differs from a later FDA presentation using the same identifier; the amendment or naming history remains unresolved. This supports a public institutional funding link, without establishing Nolan as the named principal investigator or a classified programme.
◧ Partial root native PDF text and selected layout review
The 2024 Edition of this oversight provision distinguishes case-specific withholding from supplying information and justification to committee leadership. Its annual-report wording also carries a termination note referring to December 2021. Cross-referenced provisions and later changes have not been collated, so current application remains unverified. This is historical statutory context for programme-access claims, not evidence that a UAP programme existed or anyone obtained access.
■ Complete returned historical section; current application unreviewed
National Institutes of Health. api.reporter.nih.gov.
Official NIH metadata returns two FY2021 application records for 3U19AI100627-09S2, both naming Scripps as recipient and the same amount. Their contact PIs are Garry P. Nolan and Richard J. Ulevitch; Sage appears in neither PI list. Shared identifiers and differing dates do not establish two independent awards or their administrative relationship. The paper’s Sage/Nolan support acknowledgement is preserved as a different fact from registered PI metadata. No classified approach, agency adoption or UAP involvement is established.
■ Official award metadata only; scientific and award bodies unreviewed
The 2024 Edition sets conditions for presidential covert-action findings and congressional reporting. Restricted access retains reasons, periodic review and committee notice/records. Its covert-action definition concerns unacknowledged overseas influence and excludes specified intelligence, military, diplomatic and other activities; secrecy alone does not establish that classification. The text also prohibits specified domestic influence. This is historical legal context, with later changes and current application unverified; it proves no specific UAP programme or achieved access.
■ Complete historical section scope; current application unreviewed
A curated public selection. Source review describes what was read; it does not establish that a claim is true. Our research approach